medroxyprogesterone acetate has been researched along with Atrophy in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (72.73) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Irahara, M; Takikawa, M; Uemura, H; Yasui, T | 1 |
| Cancelo, MJ; Castelo-Branco, C; Palacios, S; Vázquez, F | 1 |
| Alford, WS; Hopkins, MP | 1 |
| Mol, JA; Selman, PJ; van den Ingh, TS; van Garderen, E | 1 |
| Baracat, EC; Bortoletto, CC; Gonçalves, WJ; Lima, GR; Stávale, JN | 1 |
| Felix, JC; Moyer, DL | 1 |
| Denny, L; Kuhn, L; Pollack, AE; Wright, TC | 1 |
| Bachmann, G; Pickar, JH; Pinkerton, JV; Shoupe, D; Utian, WH | 1 |
| Avari, KM; Bhiwgade, DA | 1 |
| Baracchini, P; Bernardini, L; de Cecco, L; Ferraiolo, A; Fulcheri, E; Gerbaldo, D; Pescetto, G | 1 |
| Fraser, DI; Hillard, TC; Pryse-Davies, J; Siddle, NC; Whitehead, MI | 1 |
1 review(s) available for medroxyprogesterone acetate and Atrophy
| Article | Year |
|---|---|
Hormone replacement therapy in postmenopausal women.
Topics: Administration, Cutaneous; Atrophy; Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Osteoporosis, Postmenopausal; Postmenopause; Randomized Controlled Trials as Topic; Risk; Vagina | 2003 |
3 trial(s) available for medroxyprogesterone acetate and Atrophy
| Article | Year |
|---|---|
Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
Topics: Administration, Cutaneous; Administration, Intravaginal; Adult; Atrophy; Colposcopy; Contraceptive Agents, Female; Dose-Response Relationship, Drug; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Papanicolaou Test; Postmenopause; Treatment Outcome; Urologic Diseases; Vagina; Vaginal Creams, Foams, and Jellies; Vaginal Diseases; Vaginal Smears | 2005 |
Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate.
Topics: Adult; Animals; Atrophy; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Flushing; Horses; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Progesterone Congeners; Severity of Illness Index; Vagina | 2001 |
Endometrial response in sequential cyclic therapy assessed with associated hysteroscopy and histology.
Topics: Adult; Atrophy; Endometrial Hyperplasia; Endometrium; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hysteroscopy; Medroxyprogesterone Acetate; Middle Aged | 1992 |
7 other study(ies) available for medroxyprogesterone acetate and Atrophy
| Article | Year |
|---|---|
Endometrial rollerball ablation.
Topics: Antineoplastic Agents; Atrophy; Danazol; Dilatation and Curettage; Electrocoagulation; Endometrium; Estrogen Antagonists; Female; Humans; Hysteroscopy; Leuprolide; Medroxyprogesterone Acetate; Menorrhagia; Preoperative Care; Retrospective Studies; Tamoxifen; Treatment Outcome | 1996 |
Comparison of the histological changes in the dog after treatment with the progestins medroxyprogesterone acetate and proligestone.
Topics: Adrenal Cortex; Animals; Antineoplastic Agents, Hormonal; Atrophy; Chemical and Drug Induced Liver Injury; Contraceptive Agents, Female; Delayed-Action Preparations; Dog Diseases; Dogs; Female; Fibroadenoma; Hysterectomy; Kidney Diseases; Liver Diseases; Mammary Neoplasms, Animal; Medroxyprogesterone Acetate; Ovariectomy; Progesterone; Progesterone Congeners | 1995 |
Transvaginal ultrasonography and the progestogen challenge test in postmenopausal endometrial evaluation.
Topics: Atrophy; Biopsy; Endometrium; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Sensitivity and Specificity; Ultrasonography | 1997 |
The effects of progesterone and progestins on endometrial proliferation.
Topics: Atrophy; Biopsy; Cell Division; Contraceptives, Oral; Cyclins; Endometrium; Female; Humans; Medroxyprogesterone Acetate; Mestranol; Middle Aged; Mitosis; Norethindrone; Norethindrone Acetate; Norethynodrel; Postmenopause; Premenopause; Progesterone Congeners; Proliferating Cell Nuclear Antigen; Stromal Cells | 1998 |
Prevalence of visible disruption of cervical epithelium and cervical ectopy in African women using Depo-Provera.
Topics: Adult; Aged; Aging; Atrophy; Cervix Uteri; Contraceptive Agents, Female; Epithelium; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Odds Ratio; Parity; South Africa; Ulcer; Uterine Cervical Diseases; Uterine Cervicitis | 1999 |
Effect of depot medroxyprogesterone acetate and testosterone ananthate on the testis of albino rats: ultrastructural and biochemical studies.
Topics: Animals; Atrophy; Cholesterol; Female; Fertility; Hydrolases; Leydig Cells; Lipid Metabolism; Male; Medroxyprogesterone Acetate; Microscopy, Electron; Oxidoreductases; Pregnancy; Proteins; Rats; Sertoli Cells; Testis; Testosterone | 1992 |
Continuous combined conjugated equine estrogen-progestogen therapy: effects of medroxyprogesterone acetate and norethindrone acetate on bleeding patterns and endometrial histologic diagnosis.
Topics: Amenorrhea; Atrophy; Drug Therapy, Combination; Endometrium; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Time Factors; Uterine Hemorrhage | 1992 |